
Sapphire Lifesciences Private Limited
Pharmaceutical contract manufacturing enterprise with WHO-GMP certified plant in Maharashtra.
Pharmaceutical contract manufacturing enterprise with WHO-GMP certified plant in Maharashtra.
Sapphire Lifesciences Private Limited (SLPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 26 February 1990 and has a history of 35 years. Its registered office is in Thane, Maharashtra, India.
The Corporate was formerly known as Saphire Capules Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 13.50 Cr and a paid-up capital of Rs 13.13 Cr.
The company currently has active open charges totaling ₹32.95 Cr. The company has closed loans amounting to ₹7.22 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Sapphire Lifesciences Private Limited India is Afshan Shaikh as COMPANY SECRETARY. Ganesh Baburaya and Parag Shah serve as directors at the Company.
Thane, Maharashtra, India
+91-XXXXXXXXXX
U24239MH1990PTC055572
055572
Private Limited Indian Non-Government Company
26 Feb 1990
30 Sep 2023
31 Mar 2023
Unlisted
Roc Mumbai
Name | Designation | Appointment Date | Status |
---|---|---|---|
Afshan Shaikh ![]() | Company Secretary | 01-Apr-2016 | Current |
Name | Designation | Appointment Date | Status |
---|---|---|---|
Parag Shah ![]() | Director | 30-Mar-2004 | Current |
Ganesh Baburaya ![]() | Director | 27-Nov-2018 | Current |
Sapphire Lifesciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 70.37% increase. The company also saw a substantial improvement in profitability, with a 235.95% increase in profit. The company's net worth Soared by an impressive increase of 32.66%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2022, Sapphire Lifesciences had a promoter holding of 92.03% and a public holding of 7.97%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
₹32.95 Cr
₹7.22 Cr
Date | Lender | Amount | Status |
---|---|---|---|
03 May 2017 | Others | ₹3.00 Cr | Open |
28 Feb 2013 | Others | ₹29.95 Cr | Open |
03 Sep 2020 | Others | ₹8.18 M | Satisfied |
26 May 2020 | Others | ₹1.25 Cr | Satisfied |
30 Dec 2015 | Central Bank Of India | ₹1.50 Cr | Satisfied |
Unlock and access historical data on people associated with Sapphire Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sapphire Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sapphire Lifesciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Others of Rs. 29.95 Cr registered on 28 Feb 2013 with Charge ID 10410241 was modified on 15 Mar 2024.
Sapphire Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Sapphire Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.
A charge registered on 26 May 2020 via Charge ID 100338769 with Others was fully satisfied on 30 Mar 2023.
A charge registered on 03 Sep 2020 via Charge ID 100385849 with Others was fully satisfied on 24 Mar 2021.
A charge with Others amounted to Rs. 0.82 Cr with Charge ID 100385849 was registered on 03 Sep 2020.
Sapphire Lifesciences Private Limited was incorporated on 26 Feb 1990.
The authorized share capital of Sapphire Lifesciences Private Limited is ₹ 13.50 Cr and paid-up capital is ₹ 13.13 Cr.
Currently 3 directors are associated with Sapphire Lifesciences Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Sapphire Lifesciences Private Limited is Plot No. 44 45 Taluka Ind. Co-Op Estate Ltd. Boisar Road, India, Palghar, Maharashtra, 401404.
The corporate identification number (CIN) of Sapphire Lifesciences Private Limited is U24239MH1990PTC055572 and the company number is 055572 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2022, the revenue trend for Sapphire Lifesciences Private Limited has risen by 70.37%.
The financial reports for the fiscal year 2022 indicates that The net worth of Sapphire Lifesciences Private Limited has experienced an upsurge of 32.66%.
As per the financial statements for fiscal Year 2022, The total open charges for Sapphire Lifesciences Private Limited amount to ₹ 32.95 Cr.
The most recent Balance Sheet for Sapphire Lifesciences Private Limited was filed with the ROC on 31 Mar 2023.
Search company & director profiles for free and gain access to critical business data.
AF